Genscript Biotech 過去の業績
過去 基準チェック /06
Genscript Biotechの収益は年間平均-8.7%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間20.8% 26.5%割合で 増加しています。
主要情報
-8.7%
収益成長率
-6.4%
EPS成長率
Life Sciences 業界の成長 | 41.4% |
収益成長率 | 26.5% |
株主資本利益率 | -17.8% |
ネット・マージン | -17.5% |
前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)
Nov 19Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?
Oct 01What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?
Sep 16After Leaping 44% Genscript Biotech Corporation (HKG:1548) Shares Are Not Flying Under The Radar
Aug 02Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch
Jun 05A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)
May 10Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 13Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%
Mar 13Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jan 26Is Genscript Biotech (HKG:1548) A Risky Investment?
Nov 21Is Genscript Biotech (HKG:1548) A Risky Investment?
Aug 22Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook
Apr 04Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report
Apr 03Is Genscript Biotech (HKG:1548) A Risky Investment?
Apr 02Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate
Feb 07What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?
Dec 14Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate
Nov 09Is Genscript Biotech (HKG:1548) Using Debt Sensibly?
Oct 22Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?
Apr 03Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?
Oct 03Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?
Sep 07Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)
Aug 16Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?
Jun 03Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?
May 13Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?
Apr 16Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?
Mar 20Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?
Feb 13Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?
Jan 09収支内訳
収支内訳
Genscript Biotech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Jun 24 | 1,010 | -177 | 424 | 462 |
31 Mar 24 | 925 | -136 | 408 | 447 |
31 Dec 23 | 840 | -95 | 393 | 433 |
30 Sep 23 | 773 | -140 | 383 | 426 |
30 Jun 23 | 707 | -185 | 374 | 420 |
31 Mar 23 | 667 | -206 | 363 | 405 |
31 Dec 22 | 626 | -227 | 352 | 390 |
30 Sep 22 | 598 | -315 | 354 | 375 |
30 Jun 22 | 570 | -403 | 356 | 361 |
31 Mar 22 | 530 | -381 | 330 | 360 |
31 Dec 21 | 490 | -359 | 303 | 358 |
30 Sep 21 | 483 | -265 | 270 | 341 |
30 Jun 21 | 454 | -183 | 235 | 323 |
31 Mar 21 | 422 | -194 | 216 | 293 |
31 Dec 20 | 391 | -205 | 197 | 263 |
30 Sep 20 | 354 | -194 | 171 | 251 |
30 Jun 20 | 318 | -183 | 146 | 239 |
31 Mar 20 | 296 | -140 | 136 | 212 |
31 Dec 19 | 273 | -97 | 126 | 186 |
30 Sep 19 | 257 | -59 | 112 | 148 |
30 Jun 19 | 241 | -22 | 98 | 109 |
31 Mar 19 | 236 | 0 | 89 | 92 |
31 Dec 18 | 231 | 21 | 79 | 74 |
30 Sep 18 | 216 | 24 | 72 | 58 |
30 Jun 18 | 201 | 27 | 65 | 41 |
31 Mar 18 | 177 | 26 | 56 | 30 |
31 Dec 17 | 153 | 26 | 47 | 18 |
30 Sep 17 | 139 | 27 | 48 | 11 |
30 Jun 17 | 125 | 28 | 49 | 5 |
31 Mar 17 | 120 | 27 | 50 | 2 |
31 Dec 16 | 115 | 26 | 51 | 0 |
30 Sep 16 | 107 | 26 | 50 | 0 |
30 Jun 16 | 99 | 25 | 48 | 0 |
31 Mar 16 | 93 | 21 | 47 | 0 |
31 Dec 15 | 87 | 18 | 46 | 0 |
30 Sep 15 | 82 | 13 | 43 | 0 |
30 Jun 15 | 78 | 8 | 39 | 0 |
31 Mar 15 | 74 | 7 | 38 | 0 |
31 Dec 14 | 70 | 6 | 37 | 0 |
31 Dec 13 | 60 | 6 | 29 | 0 |
質の高い収益: 1548は現在利益が出ていません。
利益率の向上: 1548は現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 1548は利益が出ておらず、過去 5 年間で損失は年間8.7%の割合で増加しています。
成長の加速: 1548の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: 1548は利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( -3.9% ) と比較することは困難です。
株主資本利益率
高いROE: 1548は現在利益が出ていないため、自己資本利益率 ( -17.82% ) はマイナスです。